Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

L-arginine Supplement for the Prevention of Calcineurin Inhibitor Nephrotoxicity

NCT00587418 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT00587418
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00587418 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
L-arginine Supplement for the Prevention of Calcineurin Inhibitor Nephrotoxicity
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2008
Completion date
July 31, 2012
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver transplant recipients